Enhanced expression of the CXCR4 co-receptor in HIV-1-infected individuals correlates with the emergence of syncytia-inducing strains

Cytokines, Cellular and Molecular Therapy

Volumn 6, Issue 1, 2000, Pages 19-24

  Manetti, R ^a   Cosmi, L ^a   Galli, G ^a   Annunziato, F ^a   Mazzetti, M ^a   Romagnani, S ^a   Maggi, E ^a  

^a Department of Internal Medicine   (Italy)

Author keywords

AIDS; CD4; CXCR4; HAART; HIV 1

Indexed keywords

ANTIRETROVIRUS AGENT; CHEMOKINE RECEPTOR CXCR4; DIDANOSINE; INDINAVIR; LAMIVUDINE; PROTEINASE INHIBITOR; RITONAVIR; RNA DIRECTED DNA POLYMERASE INHIBITOR; SAQUINAVIR; STAVUDINE; ZIDOVUDINE;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; CORRELATION FUNCTION; FEMALE; FLOW CYTOMETRY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROTEIN EXPRESSION; T LYMPHOCYTE; TREATMENT OUTCOME; VIRUS LOAD; VIRUS PATHOGENESIS; VIRUS STRAIN;

EID: 0033843212     PISSN: 13684736     EISSN: None     Source Type: Journal    
DOI: 10.1080/13684730050515877     Document Type: Article

References (26)

1. + cells is mediated by the chemokine receptor CC-CKR-5
2. Identification of a major co-receptor for primary isolates of HIV-1
3. CC-CKR5: A RANTES, MIP-1α, MIP-1β receptor as a fusion cofactor for macrophage-tropic HIV-1
4. CCR5 levels and expression pattern correlate with infectability by macrophage-tropic HIV-1 in vitro
5. HIV-1 entry cofactor: Functional cDNA cloning of a seven-transmembrane G protein-coupled receptor
6. A seven transmembrane domain receptor involved in fusion and entry of T-cell tropic human immunodeficiency virus type-1 strains
7. The lymphocyte chemoattractant SDF1 is a ligand for LESTR/fusin and blocks HIV-1 entry
8. STRL33, a novel chemokine receptor-like protein, functions as a fusion cofactor for both macrophage-tropic and T cell line-tropic HIV1
9. A dual-tropic primary HIV-1 isolate that uses fusin and the β-chemokine receptors CKR-5, CKR-3 and CKR-2b as fusion cofactors
10. In vivo evolution of HIV-1 co-receptor usage and sensitivity to chemokine-mediated suppression
11. + T lymphocyte decline and clinical progression in human immunodeficiency virus type 1-infected individuals
12. Human immunodeficiency virus type 1 variants with increased replicative capacity develop during the asymptomatic stage before disease progression
13. Viral phenotype and immune response in primary human immunodeficiency virus type 1 infection
14. The β-chemokine receptors CCR3 and CCR5 facilitate infection by primary HIV-1 isolates
15. Change in coreceptor use correlates with disease progression in HIV-1 infected individuals
16. Biological cloning of functionally diverse quasispecies of HIV-1 AIDS
17. Early reduction of immune activation in lymphoid tissue following highly active HIV therapy
18. Expression of chemokine receptors CXCR4 and CCR5 in HIV-1-infected and uninfected individuals
19. Enhanced HIV expression during T helper 2-oriented responses due to the opposite regulatory effect of IL-4 and IFN-γ on fusin/CXCR4
20. IL-4 induces functional cell-surface expression of CXCR4 on human T cells
21. + T lymphocytes and enhance HIV-1 replication
22. Assessment of chemokine receptor expression by human Th1 and Th2 cells in vitro and in vivo
23. + T cells
24. + T cells from human immunodeficiency virus-infected asymptomatic individuals
25. Programmed death of T cells in HIV-1 infection
26. + T cells